OCC 20.9% 66.5¢ orthocell limited

Reminder - J&J ATI Rotator Cuff clinical trial update coming soon, page-6

  1. 151 Posts.
    lightbulb Created with Sketch. 96
    Hi mangoman, if you go to twitter or google and type in #orthobiologics you’ll see this is a massively competitive field. I’m invested in orthocell because I believe they are putting the research effort in, are building credibility with successful clinical trials, and have a strong chance of forming joint ventures or being bought out completely by De Puy/ J&J and I’m supporting a great home grown research to clinical story. But do your own research, and all the best.
    https://hotcopper.com.au/data/attachments/1780/1780025-ddd642fcaf9a2403a0441195b3dd82fb.jpg

 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.